CLINICAL ENDOCRINOLOGY

Obesity can be associated with several endocrine alterations arising as a result of changes in the hypothalamic-pituitary hormones axes. These include hypothyroidism, Cushing’s disease, hypogonadism and growth hormone deficiency. Adipose tissue has many other important functions that can be mediated through hormones or substances synthesized and released by adipocytes which include leptin and adiponectin. Hypothyroidism is a common clinical problem seen in obese patients and could contribute to the presence of symptoms such as fatigue and inability to concentrate. Hypogonadism and growth hormone deficiencies are both associated with abdominal obesity. The treatment of these two conditions can result in improving conditioning, muscle strength, and stamina in weight loss, improved metabolic profile, and improved bone density.

 

  • Hormones as a risk factor for obesity
  • Thyroid Disorders
  • Adrenal and Pituitary Tumors
  • Obesity on Leptin

Related Conference of CLINICAL ENDOCRINOLOGY

March 27-28, 2024

10th International Conference on Gynecology and Obstetrics

Amsterdam, Netherlands
April 11-12, 2024

7th International Conference on Obesity and Chronic Diseases

Amsterdam, Netherlands
June 10-11, 2024

24th Global Summit on Obesity

Dubai, UAE
June 27-28, 2024

20th Euro Obesity and Endocrinology Congress

London, UK
August 29-30, 2024

18th International Conference on Obesity Medicine

Helsinki, Finland

CLINICAL ENDOCRINOLOGY Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in